Kewaunee Scientific Corporation

DB:KEW Stock Report

Market Cap: €148.9m

Kewaunee Scientific Past Earnings Performance

Past criteria checks 6/6

Kewaunee Scientific has been growing earnings at an average annual rate of 66.7%, while the Medical Equipment industry saw earnings declining at 1.1% annually. Revenues have been growing at an average rate of 9.6% per year. Kewaunee Scientific's return on equity is 31.3%, and it has net margins of 9.4%.

Key information

66.7%

Earnings growth rate

66.3%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate9.6%
Return on equity31.3%
Net Margin9.4%
Last Earnings Update31 Oct 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Kewaunee Scientific makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:KEW Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Oct 2420019410
31 Jul 2420218400
30 Apr 2420419380
31 Jan 242019320
31 Oct 232157320
31 Jul 232194320
30 Apr 232191300
31 Jan 23215-1300
31 Oct 22195-3280
31 Jul 22180-6260
30 Apr 22169-6260
31 Jan 22158-9260
31 Oct 21151-7260
31 Jul 21151-4270
30 Apr 21147-4260
31 Jan 21143-2250
31 Oct 20144-4270
31 Jul 20145-6260
30 Apr 20148-5260
31 Jan 20148-5270
31 Oct 19146-3250
31 Jul 191441240
30 Apr 191472240
31 Jan 191564230
31 Oct 181625240
31 Jul 181666240
30 Apr 181585230
31 Jan 181485220
31 Oct 171405210
31 Jul 171354200
30 Apr 171395200
31 Jan 171384190
31 Oct 161405190
31 Jul 161354180
30 Apr 161294170
31 Jan 161253170
31 Oct 151203160
31 Jul 151193170
30 Apr 151194170
31 Jan 151164170
31 Oct 141144160
31 Jul 141104160
30 Apr 141114160
31 Jan 141164160

Quality Earnings: KEW has high quality earnings.

Growing Profit Margin: KEW's current net profit margins (9.4%) are higher than last year (3.2%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: KEW has become profitable over the past 5 years, growing earnings by 66.7% per year.

Accelerating Growth: KEW's earnings growth over the past year (170.4%) exceeds its 5-year average (66.7% per year).

Earnings vs Industry: KEW earnings growth over the past year (170.4%) exceeded the Medical Equipment industry 10.1%.


Return on Equity

High ROE: KEW's Return on Equity (31.3%) is considered high.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 03:00
End of Day Share Price 2024/12/18 00:00
Earnings2024/10/31
Annual Earnings2024/04/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Kewaunee Scientific Corporation is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullCG Capital